Search results
Abbott secures FDA clearance for two over-the-counter glucose monitors
Reuters via Yahoo News· 1 day ago(Reuters) -Abbott Laboratories said on Monday the U.S. health regulator had cleared the company's...
Cresset Asset Management LLC Has $25.60 Million Stock Position in Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 15 hours agoCresset Asset Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% during the fourth quarter, according to the company in its most recent disclosure with ...
2 Magnificent Dividend Growth Stocks to Buy Now
Motley Fool via Yahoo Finance· 9 hours agoDividend growth stocks have long been revered by investors as powerful vehicles for compounding wealth over the long term. By consistently increasing...
FDA approves two new Abbott over-the-counter continuous glucose monitors
CNBC· 1 day agoAbbott Laboratories announced on Monday it received approval from the U.S. Food and Drug...
Trump-backed candidate ends primary debate with explosive allegation
Fox News· 52 minutes agoTrump-endorsed U.S. Senate candidate Trent Staggs closed out his time on stage at a Republican...
Abbott Laboratories's Options: A Look at What the Big Money is Thinking - Abbott Laboratories...
Benzinga· 1 day agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories ABT , and it's something market players shouldn't ignore. Our tracking of public options ...
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 1 day agoAbbott Laboratories gained U.S. clearance Monday for a pair of new continuous glucose monitors. But...
Is Abbott Laboratories (NYSE:ABT) the Best Value Dividend Aristocrat Stock?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
Forbes· 2 days agoAbbott Laboratories Monday said the U.S. Food and Drug Administration has cleared for sale two new...
Abbott Laboratories loses bid to halt Glucerna class action
Reuters· 5 days agoLitigation claiming that Abbott Laboratories is marketing Glucerna shakes and nutritional powders with harmful ingredients can move forward, a California federal judge said Wednesday. , opens ...